Fenofibrate 145 mg

DRUG5 trials

Sponsors

Abbott, University of Padova, University of Oxford, University of Colorado, Denver, Mario Luca Morieri

Conditions

Cardiovascular DiseasesDiabetesDiabetic RetinopathyDyslipidemiaKlinefelter SyndromePharmacogenomic Drug InteractionType 2 Diabetes

Phase 3

A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg and Fenofibrate/Simvastatin 145/40mg Tablets Versus Fenofibrate or Simvastatin Monotherapies in Subjects With Abnormal Blood Levels of Fats (Lipids) and at High Risk of Cardiovascular Disease

CompletedNCT01674712

AbbottDyslipidemia

Start: 2012-06-30End: 2013-10-31Updated: 2014-12-11

Phase 4

Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes

CompletedNCT01927315

University of PadovaDiabetes, Diabetic Retinopathy

Start: 2013-08-31End: 2019-12-31Updated: 2019-12-19

Lowering Events in Non-proliferative Retinopathy in Scotland

CompletedNCT03439345

University of OxfordDiabetic Retinopathy

Start: 2018-07-23End: 2024-02-16Updated: 2025-05-14

Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males with Klinefelter Syndrome

Active, not recruitingNCT05498090

University of Colorado, DenverKlinefelter Syndrome

Start: 2022-11-03End: 2025-08-30Target: 44Updated: 2024-10-16

Unknown Phase

Genetic-Dependent Cardiovascular Response to PPAR-Alpha Agonist Fenofibrate

CompletedNCT05542147

Mario Luca MorieriCardiovascular Diseases, Pharmacogenomic Drug Interaction, Type 2 Diabetes

Start: 2022-07-03End: 2024-11-30Updated: 2025-08-11

Related Papers

Effect of Fenofibrate on Progression of Diabetic Retinopathy

NEJM Evidence2024-06-2160 citations

Design, recruitment and baseline characteristics of the <scp>LENS</scp> trial

Diabetic Medicine2024-02-224 citations

Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial.

2021-08-0915 citations